Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00914147 · ClinicalTrials.gov registry record · NA
Lung Function Testing in Patients With Locally Advanced or Metastatic Solid Tumors
A NA study, sponsored by Barbara Ann Karmanos Cancer Institute.
- Completed
- Registry status
- NA
- Development phase
- 48
- Enrollment target
NCT00914147 is a NA study that has completed, run by Barbara Ann Karmanos Cancer Institute. The registered enrollment target is 48 participants.
The verdict
NCT00914147, a NA study, has completed, sponsored by Barbara Ann Karmanos Cancer Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 48 participants
- Enrollment target
Study Summary
RATIONALE: Measuring how well the lungs work in patients with cancer may help doctors predict how patients will respond to treatment and help plan the best treatment. PURPOSE: This clinical trial is studying lung function testing in patients with locally advanced or metastatic solid tumors.
Interventions
- PROCEDURE pulmonary function testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2009-05 |
| Est. Completion | 2012-08-23 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00914147
The ClinicalTrials.gov registry entry for NCT00914147 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Barbara Ann Karmanos Cancer Institute, which has 139 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which pulmonary function testing is the first listed.
NCT00914147 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00914147 about?
NCT00914147 is a clinical study titled "Lung Function Testing in Patients With Locally Advanced or Metastatic Solid Tumors". RATIONALE: Measuring how well the lungs work in patients with cancer may help doctors predict how patients will respond to treatment and help plan the best treatment. PURPOSE: This clinical trial is studying lung function testing in patients with locally advanced or metastatic solid tumors.
What is the current status of trial NCT00914147?
This trial is currently completed. It is a NA study. The enrollment target is 48 participants. The study started on 2009-05. Estimated completion is 2012-08-23.
What interventions are being tested in trial NCT00914147?
The interventions under investigation include: pulmonary function testing (PROCEDURE).
Who is sponsoring clinical trial NCT00914147?
This trial is sponsored by Barbara Ann Karmanos Cancer Institute, which has 139 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.